Turning Point Therapeutics Announces Early Clinical Data for Repotrectinib in NTRK Fusion-Positive Advanced Solid Tumors Selected for Late-Breaker Plenary Presentation at 2021 AACR-NCI-EORTC Conference

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence